ArticleClinical Medicine Insights. Oncology2026
Prevalence of High-Risk Human Papillomavirus Infection and Associated Risk Factors Among Women Attending the Gynecology Unit in Bahir Dar, Northwest Ethiopia.
Article in Clinical Medicine Insights. Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Persistent infection with high-risk human papillomavirus (HR-HPV), particularly types 16 and 18, is the primary cause of cervical cancer The objective of this study was to determine the prevalence of HPV types 16 and 18 and identify associated risk factors among women attending the gynecology unit in Bahir Dar, northwest Ethiopia. Methods: An institution-based cross-sectional study was conducted among women attending the gynecology unit in Bahir Dar, northwest Ethiopia. A total of 344 women were selected and screened for HPV DNA. Data were collected between January and December 2025, analyzed using SPSS version 26. Cervical samples were collected and tested for HPV genotypes using the Abbott RealTime PCR System. Bivariable and multivariable logistic regression analyses were performed. Adjusted odds ratios with 95% confidence intervals were used to determine the strength of association, and a p-value <0.05 was considered statistically significant. Results: The prevalence of HPV infection was 38.4% (132/344). The prevalence of HPV-16 and HPV-18 was 18.3% and 6.7%, respectively, with a combined prevalence of 25.0%. Women aged 40-50 years (AOR ≈ 3.8) and >50 years (AOR ≈ 4.9) had higher odds of HPV infection compared with those aged 30-40 years. Divorced or widowed women were more likely to be infected than married women. Having two or more sexual partners, long-term use of hormonal contraceptives (>5 years), a history of sexually transmitted infections, and HIV-positive status (AOR = 2.37; 95% CI: 1.13-4.96) were significantly associated with HPV infection. Conclusion: The prevalence of HPV infection among women was high, with a significant portion attributed to HPV types 16 and 18. Significant predictors included older age, marital status, multiple sexual partners, long-term use of hormonal contraceptives, and HIV infection. Strengthening HPV vaccination, improving cervical cancer screening programs, and integrating HPV prevention with HIV and STI services are crucial to reducing the burden of cervical cancer in Ethiopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.